This site is intended for healthcare professionals only
LoginRegister
Panacea Biotec Gets Rs 9.82 Crore Income Tax Penalty Demand Over Alleged Income MisreportingPanacea Biotec Gets Rs 9.82 Crore Income Tax Penalty Demand Over Alleged Income Misreporting
Kerala HC Backs Drugs ControllerKerala HC Asks Centre to Assess Cancer Drug Ribociclib's Affordability Before Patent Use Decision
Natco Pharma Hikes eGenesis Investment to Rs 139 Crore, Total Exposure Rises to Rs 206 CroreNatco Pharma Hikes eGenesis Investment to Rs 139 Crore, Total Exposure Rises to Rs 206 Crore
Haryana FDA Arrests 2 More in Suspected Spurious Telma AM Racket, 4 HeldHaryana FDA Arrests 2 More in Suspected Spurious Telma-AM Racket, 4 Held
Pfizer, BioNTech, Moderna Face Patent Lawsuits as US Judge Rejects Dismissal PleasPfizer, BioNTech, Moderna Face Patent Lawsuits as US Judge Rejects Dismissal Pleas
AstraZeneca Files USFDA Application for ORPATHYS-TAGRISSO Combo in Advanced Lung CancerAstraZeneca Files USFDA Application for ORPATHYS-TAGRISSO Combo in Advanced Lung Cancer
Maharashtra FDA Introduces AI Voice-Based Portal for Fake Drug, Food Safety ComplaintsCDSCO Seeks to Strengthen Oversight of Medicines Containing Narcotic, Psychotropic Substances
Sun Pharma Inks Global Lerodalcibep Deal, Gets Rights Outside US, ChinaSun Pharma Inks Global Lerodalcibep Deal, Gets Rights Outside US, China
Lupin Gets Tentative USFDA Approval for Apixaban Oral SuspensionLupin Gets Tentative USFDA Approval for Apixaban Oral Suspension
Morepen Labs Files First US ANDA for Sitagliptin TabletsMorepen Labs Files First US ANDA for Sitagliptin Tablets in 25mg, 50mg, 100mg Strengths
USFDA Approves AbbVies Once-Daily Tavapadon for Parkinsons DiseaseUSFDA Approves AbbVie's Once-Daily Tavapadon for Parkinson's Disease
India Among Countries Getting Zero US Tariffs on Select Specialty Pharma ProductsIndia Among Countries Getting Zero US Tariffs on Select Specialty Pharma Products
X